Interestingly, AQP4 has been identified as the target for NMO-IgG, a unique feature of the disease which differentiates it from multiple sclerosis [43-45], making it a very useful differential diagnostic tool in the clinics. The gene discussed is AQP4; the disease is neuromyelitis optica.